204 related articles for article (PubMed ID: 30136914)
1. Ginsenoside Rg3 Inhibition of Thyroid Cancer Metastasis Is Associated with Alternation of Actin Skeleton.
Wu W; Zhou Q; Zhao W; Gong Y; Su A; Liu F; Liu Y; Li Z; Zhu J
J Med Food; 2018 Sep; 21(9):849-857. PubMed ID: 30136914
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis.
Xu TM; Cui MH; Xin Y; Gu LP; Jiang X; Su MM; Wang DD; Wang WJ
Chin Med J (Engl); 2008 Aug; 121(15):1394-7. PubMed ID: 18959116
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng.
Mochizuki M; Yoo YC; Matsuzawa K; Sato K; Saiki I; Tono-oka S; Samukawa K; Azuma I
Biol Pharm Bull; 1995 Sep; 18(9):1197-202. PubMed ID: 8845804
[TBL] [Abstract][Full Text] [Related]
4. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg3 Inhibits Migration and Invasion of Nasopharyngeal Carcinoma Cells and Suppresses Epithelial Mesenchymal Transition.
Wang D; Wu C; Liu D; Zhang L; Long G; Hu G; Sun W
Biomed Res Int; 2019; 2019():8407683. PubMed ID: 30915362
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE‑cadherin/EphA2/MMP9/MMP2 expression.
Guo JQ; Zheng QH; Chen H; Chen L; Xu JB; Chen MY; Lu D; Wang ZH; Tong HF; Lin S
Int J Oncol; 2014 Sep; 45(3):1065-72. PubMed ID: 24938458
[TBL] [Abstract][Full Text] [Related]
7. Anti-Metastasis Effects of Ginsenoside Rg3 in B16F10 Cells.
Lee SG; Kang YJ; Nam JO
J Microbiol Biotechnol; 2015 Dec; 25(12):1997-2006. PubMed ID: 26370799
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells.
Kim JW; Jung SY; Kwon YH; Lee JH; Lee YM; Lee BY; Kwon SM
Cancer Biol Ther; 2012 May; 13(7):504-15. PubMed ID: 22406998
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of ginsenoside Rg3 in melanoma through downregulation of the ERK and Akt pathways.
Meng L; Ji R; Dong X; Xu X; Xin Y; Jiang X
Int J Oncol; 2019 Jun; 54(6):2069-2079. PubMed ID: 31081060
[TBL] [Abstract][Full Text] [Related]
10. The angiosuppressive effects of 20(R)- ginsenoside Rg3.
Yue PY; Wong DY; Wu PK; Leung PY; Mak NK; Yeung HW; Liu L; Cai Z; Jiang ZH; Fan TP; Wong RN
Biochem Pharmacol; 2006 Aug; 72(4):437-45. PubMed ID: 16793023
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling.
Yang X; Zou J; Cai H; Huang X; Yang X; Guo D; Cao Y
Biomed Pharmacother; 2017 Dec; 96():1240-1245. PubMed ID: 29169725
[TBL] [Abstract][Full Text] [Related]
12. [The effects of ginsenosides Rg3 on the expressions of VEGF and KDR in human lung squamous cancer cells].
Wang X; Zheng YL; Li K; Lin N; Fan QX
Zhong Yao Cai; 2009 Nov; 32(11):1708-10. PubMed ID: 20218294
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell.
Xie Q; Wen H; Zhang Q; Zhou W; Lin X; Xie D; Liu Y
Biomed Pharmacother; 2017 Jan; 85():16-21. PubMed ID: 27930981
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
Tian L; Shen D; Li X; Shan X; Wang X; Yan Q; Liu J
Oncotarget; 2016 Jan; 7(2):1619-32. PubMed ID: 26636541
[TBL] [Abstract][Full Text] [Related]
15. Deguelin inhibits the migration and invasion of lung cancer A549 and H460 cells via regulating actin cytoskeleton rearrangement.
Zhao H; Jiao Y; Zhang Z
Int J Clin Exp Pathol; 2015; 8(12):15582-90. PubMed ID: 26884827
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary study for the roles and mechanisms of 20(R)-ginsenoside Rg3 and PEG-PLGA-Rg3 nanoparticles in the Lewis lung cancer mice].
Geng L; Fan J; Gao QL; Yu J; Hua BJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 48(3):496-501. PubMed ID: 27318914
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
Chen QY; Jiao DM; Yao QH; Yan J; Song J; Chen FY; Lu GH; Zhou JY
Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.
Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z
Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
Meng XY; Zhang Q; Li Q; Lin S; Li J
J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
[TBL] [Abstract][Full Text] [Related]
20. [The inhibition of 20(R)-ginsenoside Rg3 on the expressions of angiogenesis factors proteins in human lung adenocarcinoma cell line A549 and HUVEC304 cell].
Chen MW; Ni L; Zhao XG; Niu XY
Zhongguo Zhong Yao Za Zhi; 2005 Mar; 30(5):357-60. PubMed ID: 15806969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
